Clinical Trial Update: Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial update on immune response in children revaccinated with pneumococcal conjugate vaccine; study completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Disease

Drugs mentioned

• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Invasive Pneumococcal Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-01-05